checkAd

    EQS-News  143  0 Kommentare Relief Reports that NeuroRx has Announced that Aviptadil has been Selected for Inclusion in NIH-Sponsored Global Clinical Trial which Includes Aviptadil and Remdesivir - Seite 3


     
    End of News EQS Group News Service

    1181542  07.04.2021 

    fncls.ssp?fn=show_t_gif&application_id=1181542&application_name=news&site_id=wallstreet

    Lesen Sie auch


    EQS Group AG
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von EQS Group AG
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    EQS-News Relief Reports that NeuroRx has Announced that Aviptadil has been Selected for Inclusion in NIH-Sponsored Global Clinical Trial which Includes Aviptadil and Remdesivir - Seite 3 EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study Relief Reports that NeuroRx has Announced that Aviptadil has been Selected for Inclusion in NIH-Sponsored Global Clinical Trial which Includes Aviptadil and Remdesivir 07.04.2021 …